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The signals that regulate the differentiation of central and effectormemory T cells remain unclear. In this issue
of Immunity, Pepper et al. (2011) and Marshall et al. (2011) implicate the differential expression of transcrip-
tion factors in driving memory subtypes.The twentieth-century thinker Edward
de Bono noted ‘‘memory is what is left
when something happens and does not
completely unhappen.’’ Although he was
not referring to immunological memory,
some of the same considerations apply.
For example, after infection, antigen-
specific CD4+ T cells encounter antigen-
presenting cells (APCs), which trigger the
expansion and differentiation of naive
T cells into T effector cells and T follicular
helper (Tfh) cells. Effector CD4+ T cells
secrete cytokines, such as interferon-g
(IFN-g), interleukin-4 (IL-4), or IL-17,
whereas Tfh cells provide costimulatory
ligands and IL-21 that together promote
the proliferation, survival, and differentia-
tion of activated B cells (B cell help). Once
the pathogen is eliminated and antigen
becomes limiting, most of the responding
T cells die by apoptosis. However, some
T cells survive the contraction phase and
become memory cells. Thus, immunolog-
ical memory is the incomplete unhappen-
ing of the primary immune response.
The generation of memory T cells is the
basis of sustained immunity to a variety of
viruses, tumors, and bacteria and is there-
fore a fundamental process in the immune
response. Recent evidence shows that
the pool of memory CD4+ T cells is not
homogenous and that multiple memory-
cell subsets with different phenotypic and
functional properties are found in both
humans and mice. Memory T cells can
be broadly separated into central memory
T (Tcm) cells that express the chemokine
receptor CCR7 and recirculate through
lymphoid organs, and effector memory
T (Tem) cells that lack CCR7 and pref-
erentially home to nonlymphoid tissues.
After stimulation, Tem cells produce high
amounts of effector cytokines but exhibit
a reduced proliferative potential, suggest-
ing that they provide a first line of defense
against reinfection. By contrast, Tcm cells496 Immunity 35, October 28, 2011 ª2011 Elsecrete mainly IL-2 after restimulation but
vigorously proliferate compared to Tem
cells and are thought to maintain stable
protection against reinfection over the
long-term (Sallusto et al., 2004). Despite
years of intense study on the general
basis of memory formation, however, the
mechanisms that drive the acquisition of
Tcm and Tem cell phenotypes during
the contraction phase of the primary
response as well as the requirements for
their proper maintenance and function
remain unclear.
In Pepper et al. (2011), the authors
demonstrate that CD4+ T cells responding
to Listeria monocytogenes rapidly differ-
entiate into three subsets that can be
distinguished by differential expression
of the chemokine receptors CXCR5 and
CCR7. The first subset consists of
CXCR5loCCR7lo Th1 effector cells that
secrete IFN-g after restimulation and are
found in the red pulp. In contrast, the
CXCR5hiCCR7 Tfh cells express high
levels of the transcription factor Bcl6 and
the costimulatory ligand PD-1 and localize
in the B cell follicles. The third subset, the
CCR7+CXCR5+ Tcm-like cells, secrete
IL-2 but not IFN-g after restimulation and
are found mainly in T cell areas of the
spleen. The authors also show that,
whereas Tfh cells poorly contribute to
the memory T cell pool, a fraction of the
Th1 effector cells and the Tcm-like cells
survive the contraction phase and gen-
erate stable populations of Tem and
Tcm cells, respectively.
In Marshall et al. (2011), the authors
use different markers to demonstrate that
CD4+ T cells responding to lymphocytic
choriomeningitis virus (LCMV)differentiate
into Tfh, Th1, and Tcm-like cells during the
early stages of the primary response.
Similar to the results of Pepper et al.
(2011), they found that resting memory
CD4+ T cells poorly expressed Tfh cell-sevier Inc.associated markers but that Th1 and
Tcm-like cells survive to generate Tem
and Tcm cells that are maintained for
extended periods of time.
IFN-g-producing T cells are generated
in response to both Listeria and LCMV.
Thus, it is not surprising that T-bet, the
transcriptional regulator of Th1 cell differ-
entiation, plays a role in the differentiation
of T cells responding to these organisms.
In fact, previous studies demonstrate that
T-bet controls the differentiation of CD8+
T cells into Tcm and Tem cells (Intlekofer
et al., 2007; Joshi et al., 2007). In the ab-
sence of T-bet expression, CD8+ T cells
differentiate into Tcm cells that predomi-
nantly secrete IL-2 upon restimulation
and express high amounts of CCR7 and
low amounts of the transcription factors
Blimp-1 and Eomes (Intlekofer et al.,
2007). Importantly, the development of
Tcm CD8+ T cells requires IL-7 signaling,
and T-bet represses the expression of
the IL-7Ra (Joshi et al., 2007). Based on
these data, it seems that T-bet may pro-
mote the differentiation of Tem cells at
the expense of Tcm cells by repressing
signaling through the IL-7R.
Consistent with this idea, the current
manuscripts show that T-bet is also defer-
entially expressed by CD4+ Tem and Tcm
cells. Whereas CD4+ Tem cells express
high amounts of T-bet, Tcm cells express
moderate amounts of this transcription
factor. Furthermore, they demonstrate
that T-bet deficiency compromises the
development of Tem CD4+ T cells. How-
ever, contrary to what is described for
CD8+ T cells, IL-7Rahi and IL-7Ralo CD4+
T cells express similar amounts of T-bet.
Moreover, IL-7Rahi and IL-7Ralo cells are
similarly able to generate memory CD4+
T cells. Thus, T-bet modulates the differ-
entiation of CD4+ T cells into either Tcm
or Tem by mechanisms other than the
control of IL-7Ra expression.
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Figure 1. Opposite T Cell:DC and T Cell:B Cell Interactions Promote Tem and Tcm Cell Differentiation
After encounterwith antigen-bearingDCs, naiveCD4+T cells activate and undergoexpansion. Sustained interaction of T cellswithDCs leads to IL-2and IL-12-depen-
dent T-betupregulationandsubsequent terminalTh1celldifferentiation.Sustained interactionof TcellswithBcells upregulatesBcl6and repressesT-bet,which favors
Tfh and Tcm cell development. After pathogen clearance, a fraction of Th1 and Tcm cells survives the contraction phase and become long-lived Tem and Tcm cells.
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CXCR5 and Bcl6, suggesting a common
origin with Tfh cells. However, Tfh cells
do not give rise to Tcm cells. In contrast,
Tcm cells have the capacity to generate
Tfh cells after adoptive transfer, suggest-
ing that Tcm cells are, in fact, the elusive
memory T cell precursors to the Tfh cells
that arise during secondary responses.
Whether Tfh cells represent a more termi-
nally differentiated state of Tcm cells and
what signalsmay regulate Tcm-Tfh transi-
tion are still unclear. However, the authors
demonstrate that, similar to Tfh cells, the
differentiation of Tcm cells requires Bcl6,
but not T-bet, suggesting that Bcl6 may
favor Tcm cell development by repressing
T-bet. Supporting this model, the authors
show that Bcl6-deficient CD4+ T cells ex-
press higher amounts of T-bet and ap-
pear more like Tem cells compared to
CD4+ T cells from normal animals. Impor-
tantly, Tcm cells can also differentiate into
T-bet-expressing Th1 cells after rechal-
lenge, suggesting that Bcl6 expression is
not permanent feature of Tcm cells or
their progeny and that their ability to regu-
late the expression of Bcl6 may explain
the characteristic plasticity of Tcm cells.
Conversely, T-bet expression might also
limit Bcl6 upregulation and drive CD4+
memory T cell response toward a Tem
cell phenotype. Thus, the balance be-
tween Bcl6 and T-bet expression seems
to be a fundamental mechanism control-
ling the generation of distinct memory
populations.Pepper et al. (2011) also demonstrate
that CD25, a component of the IL-2 re-
ceptor, is expressed early during the dif-
ferentiation of T-bethi cells and that sig-
naling through this receptor is required
for the normal development of Tem cells.
Strikingly, the transcription factor Blimp1,
which is also induced in response to IL-2,
represses Bcl6 expression and is pre-
ferentially expressed by effector CD25+
CD4+ T cells (Choi et al., 2011). Thus,
these results suggest that CD25 signaling
increases Blimp1 expression, which in
turn reduces Bcl6, increases T-bet, and
promotes the differentiation of Th1 effec-
tor cells. This view is in agreement with
recent results demonstrating that Blimp1
promotes CD8+ T cell terminal differentia-
tion and limits the generation of CD8+ Tcm
cells (Rutishauser et al., 2009).
The role of B cells in the control of CD4+
T cell differentiation is also striking. How-
ever, despite the mounting evidence that
B cells regulate CD4+ memory T cell gen-
eration (Lund and Randall, 2010), the
mechanisms by which B cells control this
process are still unclear. Importantly,
Pepper et al. (2011) demonstrate that the
development of Tcm cells, but not Tem
cells, requires interactions between the
costimulatory molecule, ICOS, on T cells
and its ligandonBcells. Thus, these results
suggest that B cells regulate T cellmemory
dynamics by instructing the development
of Tcm cells—a view that is consistent
with observations in patients treated with
the CD20monoclonal antibody Rituximab.Immunity 35Given the fundamental importance of
dendritic cells (DCs) in the initial priming
of T cells, one would have to conclude
that CD4+ T cell differentiation is con-
trolled by sequential APC:T cell interac-
tions, each of which provides unique
stimuli that regulate the path of T cell
differentiation. For example, appropri-
ately activated DCs produce IL-12, which
would promote T-bet expression in re-
sponding T cells (Liao et al., 2011). More-
over, activated DCs also upregulate costi-
mulatory ligands, such as CD70, which
triggers IL-2 production and favors Th1
cell differentiation (Soares et al., 2007).
Thus, sustained interactions with DCs
may favor terminal Th1 cell differentiation
by repressing Bcl6 and promoting T-bet in
an IL-2- and IL-12-dependent mechanism
(Figure 1). However, at later times in an
immune response, when antigen avail-
ability is limited, B cells may be the pri-
mary APCs. As a consequence, the re-
sponding CD4+ T cells would probably
encounter different costimulatory recep-
tors, such as ICOS and OX40, which
might repress T-bet and promote Bcl6 ex-
pression. Thus, interactions with antigen-
presenting B cells would preferentially
promote Tcm and Tfh cell differentiation.
Taken together, these new studies
show that Tfh and Tem cells are formed
when Bcl6 or T-bet, respectively, domi-
nate the transcriptional program in CD4+
T cells and that Tcm cells are formed
when these factors achieve a more
balanced state. Whether this balance, October 28, 2011 ª2011 Elsevier Inc. 497
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differentiation or simply taking the middle
way, these results offer new insight into
CD4+ T cell differentiation.
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The biology of interleukin-17C (IL-17C) has remained largely a mystery for more than a decade. Chang et al.
(2011), in this issue of Immunity, and two other reports (Song et al., 2011; Ramirez-Carrozzi et al., 2011)
demonstrate that IL-17C has broad functions in a variety of tissues.Of the six members of the IL-17 cytokine
family, three have been shown to play
prominent roles in both innate and adap-
tive immune responses, including the
founding member IL-17A, its closest
sequence homolog IL-17F, and IL-17E
(IL-25). For the remaining three family
members (IL-17B, IL-17C, and IL-17D),
very little is known regarding their tissue
expression pattern and biological func-
tion (Gaffen, 2009). IL-17C was cloned
by Li et al. (2000), who showed that it stim-
ulated THP-1 cells (a human monocytic
cell line), to produce inflammatory cyto-
kines TNFa and IL-1b. A handful of subse-
quent studies by several other groups
then showed a recurring pattern that
IL-17C was not expressed under nor-
mal conditions but was upregulated and
played significant roles in inflamed tissues
including the joint, lung, and skin (Yama-
guchi et al., 2007; Wu et al., 2007; Johan-
sen et al., 2009). Despite these advances,
IL-17C remained an orphan cytokine.
It was hitherto unclear what receptor
IL-17C engages, which cell types express
the cognate receptor, and what signaltransduction pathway mediates its func-
tion. This month, three new papers shed
light on these intriguing questions, and
the answers span both innate and adap-
tive immune responses—similar to other
IL-17 family members—in target organs
as diverse as the central nervous system
and tissues with barrier functions. Thus,
another member of the IL-17 family is
indispensable for type 17 immunity, with
its own unique signature pathway biology.
In this issue of Immunity, Chang et al.
(2011) began their study by noting that
IL-17C mRNA expression was upre-
gulated 15-fold in the central nervous
system (CNS) of mice with experimen-
tal autoimmune encephalomyelitis (EAE)
compared with naive control mice. Then
they discovered that Il17c/ mice ex-
hibited a striking reduction both in the
severity and incidence of EAE, an im-
portant observation. This phenotype was
supported at the cellular level by reduced
numbers in the CNS of total CD4+ T cells
and IL-17+, IFNg+, and double-producer
cells and at themolecular level by reduced
mRNA expression of IL-17A, IFN-g, andCCL20. These results suggested that the
lack of accumulation of pathogenic CD4+
T cells in the Il17c/ mice was the key
factor in protection from disease. The
authors conclude that the initial CD4+ Th
cell differentiation and effector genera-
tion in secondary lymphoid tissues appear
to be intact in the Il17c/ mice and that
the defects in function do not appear until
either migration or accumulation in the
CNS occurs.
The authors then generated a series of
transfectant cell lines with IL-17 receptor
family members (IL-17RA to IL-17RE),
and made a second important observa-
tion: that IL-17C-Ig fusion protein specifi-
cally and uniquely bound IL-17RE. IL-17C
most likely binds to a heterodimer of
IL-17RA and IL-17RE on the basis of
two pieces of evidence: epitope-tagged
IL-17RE brought down IL-17RA in a
co-IP assay, and Il17ra/ transfectants
of Il17re lost their responsiveness to
IL-17C treatment in vitro. IL-17RE mRNA
was upregulated in in vitro generated
Th17 cells, but not in naive, natural or
induced Treg, Th1, or Th2 cells. The
